The GLP-1 and weight loss drug landscape is teeming with innovation as companies test drugs with...

While the U.S. boasts the Magnificent Seven stocks – some of the dominant tech companies shaping...

Volatility Spiking as Market Corrects The market is staring down the barrel of multiple headwinds...

Historically, emerging market equities have earned a spot in investor portfolios under the premise...

High Expectations for Earnings Season From a profit and price perspective, the Magnificent Seven...

Originally developed for diabetes treatment, the discovery of GLP-1 therapeutics as a weight loss...

On June 14, 2024, Allan Sloan published a commentary in Barron’s with the headline “There Is No...

Addressing the Obesity Epidemic The global obesity epidemic has reached alarming proportions. Since...

Artificial Intelligence, commonly known as AI, is all set to transform our daily lives. As with...